Quantifying the Impact of Atrial Fibrillation on Heart Failure–Related Patient-Reported Outcomes in the Utah mEVAL Program is a research paper published in Journal of Cardiac Failure (2021). On theSindex it has a DataRank of 0.399. It has been cited 7 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0.0867
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
National Heart, Lung, and Blood Institute
Grant: K23HL143156
NCATS NIH HHS
Grant: UL1 TR002538
National Institutes of Health
Grant: 5K23HL143156-02
Optimizing Outcomes for Patients with Heart Failure and Atrial Fibrillation
National Institutes of Health
FWCI
0.88
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals